Skip to main content
Premium Trial:

Request an Annual Quote

GeneBio, Berlin Institute of Toxicology Partner to Create LC-MS/MS Spectra Library

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Institute of Toxicology in the Clinical Toxicology and Poison Information Centre Berlin is collaborating with Geneva Bioinformatics for use of its SmileMS software to create a library of LC-MS/MS spectra.

Thomas Grobosch and Christoph Köhler at the Institute of Toxicology have initiated a project to develop a generic screening method using a fully automated online extraction method to analyze serum or plasma samples, GeneBio said in a statement. The method includes HPLC for chromatographic separation and quadrupole time-of-flight mass spectrometry technology.

The SmileMS software will be used to optimize the identification of drugs, poisons, and toxins with their metabolites from data acquired on quadrupole time-of-flight instruments.

The "premier objective" of the collaboration is to create a dedicated MS/MS spectra library of small molecules generated by AB Sciex's QStar mass spec instrument, GeneBio said.

Terms of the deal were not disclosed.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.